We are a
Life Sciences Company that Cares

We are transforming the drug discovery and development process and accelerating the creation of life-changing psilocybin drugs on behalf of patients.

CSE: MYND / OTC: MYNDF
25_bw-wht.png

We strongly believe in supporting people suffering from neuroinflammatory diseases and we believe our research can help change lives
 

Mynd was founded by Dr. Wilfred Jefferies and Dr. Lyle Oberg with the goal of improving mental health. Dr. Jefferies is a world-renowned Neuroimmunologist with over 60 patents and 100 publications in prestigious medical journals, including Nature and The Lancet.

Through Dr. Jefferies research conducted over the past 30 years and the executive leadership of

Dr. Oberg, we intend to establish the link between depression and inflammation in the brain and ultimately develop a pharmaceutical treatment utilizing compounds found in Psilocybin.

Strength in Leadership

7AC67701-041B-4F5F-BF3D-F2668B4765E3.jpeg

Dr. Lyle Oberg

CO-FOUNDER & CEO
leadership-team-2.jpeg

Dr. Wilfred Jeffries

CO-FOUNDER &
CHIEF SCIENCE OFFICER
DSC_6987_edited.jpg

Luke Warkentin

VP CORPORATE DEVELOPMENT
lih, headshot.JPG

Lih-Ming Tam

SENIOR CONTROLLER
ChaahatSingh.jpeg

Dr. Chaahat SB Singh

OPERATIONS &
RESEARCH MANAGER
mynd-key-2.png

Dr. Iryna Saranchova

CHIEF CLINICAL OFFICER
Untitled-2.png

Board of Directors

Dr. Wilfred Jefferies

Board Chair

Dr. Lyle Oberg

Director

Roslyn Ritchie-Derrien
Director

Scott Nicoll

Director
Audit Committee Chair

Jay Campbell

Director
Compensation Committee Chair

cb31f1670cdc1493f4e2e8f35d46aed5_edited.jpg

THANK YOU

Stay Informed on Key Developments